Data Monitoring Committee Determines Alnylam's ENDEAVOUR Trial May Continue

By: via Benzinga
Morgan Stanley in a research note released Monday noted that the Data Monitoring Committee has recommended Alnylam Pharmaceuticals, ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.